Research Daily
Today's Must Read
Boeing (BA) Reports Q2 Deliveries, Ups 20-Yr Market Outlook
Kellogg's (K) Sales Trends Likely to Improve in Q2
Colgate's (CL) Growth Strategies to Combat Currency Woes
Friday, July 15, 2016
We have hand-picked 16 research reports from amongst the roughly 70 reports issued by our analyst team today, including reports for Boeing (BA), Kellogg (K) and Colgate (CL).
Boeing shares have been weak lately, reflecting uncertainty about the global commercial aviation industry on economic grounds, Which have only magnified following the Brexit vote. These challenges notwithstanding, the analyst likes the airplane manufacturer for its impressive track record of innovation, a fortress balance sheet and strong cash flows. The analyst discusses the pros and cons of investing Boeing shares at this stage in the updated research report published today. (You can read the full research report on BA here.)
Kellogg has been struggling to grow sales over the past two years mainly due to weakness in its developed market cereals and U.S. snacks businesses. But the analyst likes the cereal maker's investments in brand building, in-store capabilities and product and packaging innovation as well as reformulation of many existing products in order to improve sales trends. The stock has done really well lately and EPS estimates remain stable ahead of the company's August 4th earnings release. (You can read the full research report on K here.)
Colgate shares have gained almost 12% in the year-to-date period, likely reflecting the market's hopes of repeat performance in its June quarter report on July 28th. The company had beat sales expectations in the March quarter, which followed a long period of top-line 'misses'. The company continues to make progress with its growth and efficiency initiatives. (You can read the full research report on CL here.)
Other noteworthy reports we are featuring today include Discover Financial (DFS), Allergan (AGN) and Xcel Energy (XEL).
• Discover Financial (DFS) Raises Dividend
• Devon (DVN) Meets '16 Divesture Goal
• Allergan (AGN) Up to Zacks Rank # 2 (Buy)
• Check Point (CHKP) Down to Zacks Rank # 4 (Sell)
You can find all of today's stock research reports here.
Sheraz Mian
Director of Research
Note: Sheraz Mian regularly provides earnings analysis on Zacks.com and appears frequently in the print and electronic media. His weekly earnings related articles include Earnings Trends and Earnings Preview. He also provides weekly commentary to Zacks Premium subscribers and manages the Zacks Focus List and Top 10 portfolios.
If you want an email notification each time Sheraz publishes a new article, please click here.
Get the latest research report on BA - FREE
Get the latest research report on XEL - FREE
Get the latest research report on DFS - FREE
Get the latest research report on CL - FREE
Get the latest research report on K - FREE